Antibiotic Therapy for Cellulitis
For non-purulent cellulitis, a 5-6 day course of antibiotics active against streptococci is recommended as first-line therapy, with coverage for MRSA considered in patients who don't respond to beta-lactam therapy or have risk factors for MRSA infection. 1, 2
First-Line Treatment Options
Non-Purulent Cellulitis (No Drainage/Exudate/Abscess)
- First choice: Beta-lactam antibiotics targeting beta-hemolytic streptococci 1, 2
- Amoxicillin-clavulanate
- Cephalexin
- Penicillin
When MRSA Coverage Is Needed
Consider MRSA coverage in patients who:
- Do not respond to beta-lactam therapy
- Have systemic toxicity
- Have risk factors for MRSA (prior MRSA infection, MRSA colonization, injection drug use)
- Have penetrating trauma
MRSA Coverage Options
- Clindamycin 600mg orally three times daily 1, 2
- Trimethoprim-sulfamethoxazole (TMP-SMX) 1
- Doxycycline or minocycline (not for children <8 years) 1, 2
- Linezolid 600mg twice daily 1
Combination Therapy Options
When coverage for both beta-hemolytic streptococci and MRSA is desired:
- Clindamycin alone 1, 2
- TMP-SMX plus a beta-lactam (e.g., amoxicillin) 1, 2
- Doxycycline plus a beta-lactam 2
- Linezolid alone 1
Treatment Duration
- 5-6 days for uncomplicated cellulitis 1, 2
- Consider extending if infection hasn't improved after 5 days 2
- Multiple studies show 5-day courses are as effective as 10-day courses 3
Hospitalized Patients with Complicated SSTI
For patients requiring hospitalization:
- IV vancomycin 1
- IV/oral linezolid 600mg twice daily 1
- Daptomycin 4mg/kg/day IV 1, 4
- Telavancin 10mg/kg/day IV 1
- IV clindamycin 600mg three times daily 1
Special Considerations
Pediatric Patients
- Mupirocin 2% topical ointment for minor skin infections 1
- Avoid tetracyclines in children <8 years 1, 2
- For hospitalized children with complicated SSTI, vancomycin is recommended 1
- Clindamycin 10-13mg/kg/dose IV every 6-8h is an option if local resistance is low 1
Adjunctive Therapy
- Consider systemic corticosteroids in select adult patients to hasten resolution (contraindicated in diabetics and pregnant women) 2
- Reduce underlying edema through elevation and compression stockings 2
Prevention of Recurrent Infections
- Keep draining wounds covered with clean, dry bandages 1
- Maintain good personal hygiene 1
- Avoid reusing or sharing personal items 1
- Consider environmental hygiene measures for recurrent SSTI 1
- Identify and treat predisposing conditions (edema, obesity, eczema, venous insufficiency) 2
Common Pitfalls to Avoid
- Using TMP-SMX alone for non-purulent cellulitis (poor activity against streptococci) 2
- Using tetracyclines in children under 8 years 1, 2
- Failing to obtain cultures from abscesses and purulent drainage 1
- Not considering MRSA coverage when risk factors are present 2
- Using unnecessarily prolonged antibiotic courses when shorter durations are equally effective 1, 3
The evidence strongly supports a 5-6 day course of antibiotics for uncomplicated cellulitis, with the specific choice guided by local resistance patterns and patient-specific factors such as MRSA risk. Early recognition of treatment failure and appropriate adjustment of therapy are essential to improve outcomes and reduce complications.